Form4insider filings, from the source

SEC Form 4 · accession 0001181431-15-001720

Zosano Pharma Corp · ZSAN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Ryan D Drant
10% Owner
Period of report
Jan 30, 2015
Accepted (ET)
Feb 2, 2015 · 1:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001587221

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Jan 30, 2015C341,201$9.35A2,135,082D
Common StockF2Jan 30, 2015P23,457$11.00A2,158,539D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
8% Convertible Note Issued 9/9/2013F2,F1—Jan 30, 2015C—D—Mar 31, 2015Common Stock——D
8% Convertible Note Issued 2/26/14F2,F1—Jan 30, 2015C—D—Mar 31, 2015Common Stock——D
8% Convertible Note Issued 12/2/2014F2,F1—Jan 30, 2015C—D—Mar 31, 2015Common Stock——D

Explanation of responses